基于血糖相关基因不同亚型乳腺癌的预后模型
Prognostic Model for Breast Cancer Based on Blood Glucose-Related Genes in Different Subtypes
摘要: 乳腺癌的发病率在全球范围内呈上升趋势,也是女性中最常见的恶性肿瘤之一。本研究从TCGA数据库获取1028例乳腺癌患者的转录组数据以及相关的临床数据。在MSigDB数据库使用关键词筛选845个血糖相关的基因。对TCGA数据库中的肿瘤样本和正常样本进行差异表达分析获取7549个差异表达基因,同时将血糖相关基因集和差异表达基因取交集获得342个交集基因。使用加权基因共表达网络(WGCNA)筛选出与乳腺癌预后相关性高的黄色模块,并基于黄色模块中的基因使用一致性聚类算法对TCGA-BRCA乳腺癌样本进行最优化分组。通过单因素Cox回归分析和LASSO回归分析筛出10个与预后显著相关的基因(CLIC6、ELOVL2、KLHDC7B、KRT80、MMP12、NEK10、SEC14L2、SHCBP1、SUSD3和TAT),并基于这10基因构建了乳腺癌的风险评分模型。本研究通过一致性聚类分组后构建的乳腺癌风险评分模型也能够较好地预测患者的预后情况,为乳腺癌的预后评估及开发可能的治疗靶点提供一定依据。
Abstract: The incidence of breast cancer is on the rise globally and remains one of the most common malignant tumors among women. In this study, transcriptomic data and relevant clinical data from 1028 breast cancer patients were obtained from the TCGA database. A total of 845 blood glucose-related genes were screened using keywords from the MSigDB database. Differential expression analysis between tumor and normal samples in the TCGA database yielded 7549 differentially expressed genes. The intersection of blood glucose-related genes and differentially expressed genes resulted in 342 overlapping genes. A weighted gene co-expression network was employed to identify the yellow module, which exhibited a high correlation with breast cancer prognosis. Based on the genes within the yellow module, an optimal grouping of TCGA-BRCA breast cancer samples was achieved using a consensus clustering algorithm. Univariate Cox regression analysis and LASSO regression analysis identified 10 genes significantly associated with prognosis (CLIC6, ELOVL2, KLHDC7B, KRT80, MMP12, NEK10, SEC14L2, SHCBP1, SUSD3, and TAT). A risk scoring model for breast cancer was subsequently constructed based on these 10 genes. The risk scoring model developed after consensus clustering grouping demonstrated a robust ability to predict patient prognosis, offering valuable insights for prognostic assessment and the potential development of therapeutic targets in breast cancer.
文章引用:吴南平. 基于血糖相关基因不同亚型乳腺癌的预后模型[J]. 应用数学进展, 2025, 14(4): 536-547. https://doi.org/10.12677/aam.2025.144184

参考文献

[1] Barzaman, K., Karami, J., Zarei, Z., Hosseinzadeh, A., Kazemi, M.H., Moradi-Kalbolandi, S., et al. (2020) Breast Cancer: Biology, Biomarkers, and Treatments. International Immunopharmacology, 84, Article 106535. [Google Scholar] [CrossRef] [PubMed]
[2] Pfeiffer, R.M., Webb-Vargas, Y., Wheeler, W. and Gail, M.H. (2018) Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-Term Changes in Risk Factor Distributions. Cancer Epidemiology, Biomarkers & Prevention, 27, 1214-1222. [Google Scholar] [CrossRef] [PubMed]
[3] Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. [Google Scholar] [CrossRef] [PubMed]
[4] Mohamed, H.T., El-Shinawi, M., Nouh, M.A., Bashtar, A., Elsayed, E.T., Schneider, R.J., et al. (2014) Inflammatory Breast Cancer: High Incidence of Detection of Mixed Human Cytomegalovirus Genotypes Associated with Disease Pathogenesis. Frontiers in Oncology, 4, Article 246. [Google Scholar] [CrossRef] [PubMed]
[5] Samuel, S.M., Varghese, E., Varghese, S. and Büsselberg, D. (2018) Challenges and Perspectives in the Treatment of Diabetes Associated Breast Cancer. Cancer Treatment Reviews, 70, 98-111. [Google Scholar] [CrossRef] [PubMed]
[6] Hu, F.B. (2011) Globalization of Diabetes: The Role of Diet, Lifestyle, and Genes. Diabetes Care, 34, 1249-1257. [Google Scholar] [CrossRef] [PubMed]
[7] Shikata, K., Ninomiya, T. and Kiyohara, Y. (2012) Diabetes Mellitus and Cancer Risk: Review of the Epidemiological Evidence. Cancer Science, 104, 9-14. [Google Scholar] [CrossRef] [PubMed]
[8] Vigneri, P., Frasca, F., Sciacca, L., Pandini, G. and Vigneri, R. (2009) Diabetes and Cancer. Endocrine-Related Cancer, 16, 1103-1123. [Google Scholar] [CrossRef] [PubMed]
[9] Larsson, S.C., Mantzoros, C.S. and Wolk, A. (2007) Diabetes Mellitus and Risk of Breast Cancer: A Meta-Analysis. International Journal of Cancer, 121, 856-862. [Google Scholar] [CrossRef] [PubMed]
[10] Stattin, P., Björ, O., Ferrari, P., Lukanova, A., Lenner, P., Lindahl, B., et al. (2007) Prospective Study of Hyperglycemia and Cancer Risk. Diabetes Care, 30, 561-567. [Google Scholar] [CrossRef] [PubMed]
[11] Boyle, P., Boniol, M., Koechlin, A., Robertson, C., Valentini, F., Coppens, K., et al. (2012) Diabetes and Breast Cancer Risk: A Meta-Analysis. British Journal of Cancer, 107, 1608-1617. [Google Scholar] [CrossRef] [PubMed]
[12] Zhao, X. and Ren, G. (2016) Diabetes Mellitus and Prognosis in Women with Breast Cancer. A Systematic Review and Meta-Analysis Medicine, 95, e5602. [Google Scholar] [CrossRef] [PubMed]
[13] Peairs, K.S., Barone, B.B., Snyder, C.F., Yeh, H., Stein, K.B., Derr, R.L., et al. (2011) Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology, 29, 40-46. [Google Scholar] [CrossRef] [PubMed]
[14] Vona-Davis, L. and P. Rose, D. (2012) Type 2 Diabetes and Obesity Metabolic Interactions: Common Factors for Breast Cancer Risk and Novel Approaches to Prevention and Therapy. Current Diabetes Reviews, 8, 116-130. [Google Scholar] [CrossRef] [PubMed]
[15] Goodwin, P.J., Ennis, M., Pritchard, K.I., Trudeau, M.E., Koo, J., Taylor, S.K., et al. (2012) Insulin-and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations. Journal of Clinical Oncology, 30, 164-171. [Google Scholar] [CrossRef] [PubMed]
[16] Schrauder, M.G., Fasching, P.A., Häberle, L., Lux, M.P., Rauh, C., Hein, A., et al. (2011) Diabetes and Prognosis in a Breast Cancer Cohort. Journal of Cancer Research and Clinical Oncology, 137, 975-983. [Google Scholar] [CrossRef] [PubMed]
[17] De Bruijn, K.M.J., Arends, L.R., Hansen, B.E., Leeflang, S., Ruiter, R. and van Eijck, C.H.J. (2013) Systematic Review and Meta-Analysis of the Association between Diabetes Mellitus and Incidence and Mortality in Breast and Colorectal Cancer. British Journal of Surgery, 100, 1421-1429. [Google Scholar] [CrossRef] [PubMed]
[18] Rivenbark, A.G., O’Connor, S.M. and Coleman, W.B. (2013) Molecular and Cellular Heterogeneity in Breast Cancer. Challenges for Personalized Medicine. The American Journal of Pathology, 183, 1113-1124. [Google Scholar] [CrossRef] [PubMed]
[19] Mohamed, A., Krajewski, K., Cakar, B. and Ma, C.X. (2013) Targeted Therapy for Breast Cancer. The American Journal of Pathology, 183, 1096-1112. [Google Scholar] [CrossRef] [PubMed]
[20] Rich, J.T., Neely, J.G., Paniello, R.C., Voelker, C.C.J., Nussenbaum, B. and Wang, E.W. (2010) A Practical Guide to Understanding Kaplan-Meier Curves. OtolaryngologyHead and Neck Surgery, 143, 331-336. [Google Scholar] [CrossRef] [PubMed]
[21] Yu, G., Wang, L., Han, Y. and He, Q. (2012) Clusterprofiler: An R Package for Comparing Biological Themes among Gene Clusters. OMICS: A Journal of Integrative Biology, 16, 284-287. [Google Scholar] [CrossRef] [PubMed]
[22] Li, W., Liu, H., Qian, W., Cheng, L., Yan, B., Han, L., et al. (2018) Hyperglycemia Aggravates Microenvironment Hypoxia and Promotes the Metastatic Ability of Pancreatic Cancer. Computational and Structural Biotechnology Journal, 16, 479-487. [Google Scholar] [CrossRef] [PubMed]
[23] García-Esquinas, E., Guinó, E., Castaño-Vinyals, G., Pérez-Gómez, B., Llorca, J., Altzibar, J.M., et al. (2016) Association of Diabetes and Diabetes Treatment with Incidence of Breast Cancer. Acta Diabetologica, 53, 99-107. [Google Scholar] [CrossRef] [PubMed]
[24] Tang, Y., Wang, Y., Kiani, M.F. and Wang, B. (2016) Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer. Clinical Breast Cancer, 16, 335-343. [Google Scholar] [CrossRef] [PubMed]
[25] Wu, L. and Yang, X. (2018) Targeting the Hippo Pathway for Breast Cancer Therapy. Cancers, 10, Article 422. [Google Scholar] [CrossRef] [PubMed]
[26] Ganapathy-Kanniappan, S. (2017) Taming Tumor Glycolysis and Potential Implications for Immunotherapy. Frontiers in Oncology, 7, Article 36. [Google Scholar] [CrossRef] [PubMed]
[27] Li, L., Liang, Y., Kang, L., Liu, Y., Gao, S., Chen, S., et al. (2018) Transcriptional Regulation of the Warburg Effect in Cancer by SIX1. Cancer Cell, 33, 368-385.E7. [Google Scholar] [CrossRef] [PubMed]
[28] Cheng, X., Jia, X., Wang, C., Zhou, S., Chen, J., Chen, L., et al. (2023) Hyperglycemia Induces PFKFB3 Overexpression and Promotes Malignant Phenotype of Breast Cancer through RAS/MAPK Activation. World Journal of Surgical Oncology, 21, Article No. 112. [Google Scholar] [CrossRef] [PubMed]
[29] Gajeton, J., Krukovets, I., Muppala, S., Verbovetskiy, D., Zhang, J. and Stenina-Adognravi, O. (2021) Hyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer. Cancers, 13, Article 1346. [Google Scholar] [CrossRef] [PubMed]
[30] Dizdaroglu, M. (2012) Oxidatively Induced DNA Damage: Mechanisms, Repair and Disease. Cancer Letters, 327, 26-47. [Google Scholar] [CrossRef] [PubMed]
[31] Hirano, T. (2021) IL-6 in Inflammation, Autoimmunity and Cancer. International Immunology, 33, 127-148. [Google Scholar] [CrossRef] [PubMed]
[32] Pollak, M. (2012) The Insulin and Insulin-Like Growth Factor Receptor Family in Neoplasia: An Update. Nature Reviews Cancer, 12, 159-169. [Google Scholar] [CrossRef] [PubMed]